Related Experiment Videos
Understanding and managing microbial resistance in institutional settings
1State University of New York at Buffalo, USA.
Summary
Medically compromised "genesis patients" can harbor and spread resistant organisms. Strategies to prevent antimicrobial resistance must address patient factors and ensure optimal antibiotic selection and dosing.
Area of Science:
- Infectious Diseases
- Clinical Pharmacy
- Healthcare Management
Background:
- Antimicrobial resistance is a growing global health threat.
- Certain patient populations, termed "genesis patients," are critical reservoirs for resistant organisms.
- Understanding patient factors is key to controlling resistance spread in healthcare settings.
Purpose of the Study:
- To identify patient factors contributing to antimicrobial resistance.
- To explain the concept and significance of "genesis patients."
- To outline strategies for preventing and managing resistance, particularly in vulnerable patient groups.
Main Methods:
- Review of patient factors influencing antimicrobial resistance.
- Explanation of the "genesis patient" concept and their role in resistance.
- Analysis of antibiotic-related factors, including formulary strategies and dosing.
Main Results:
- Genesis patients, unable to clear resistant organisms, act as focal points for resistance emergence and spread.
- Suboptimal antibiotic dosing is a significant contributor to resistance development.
- Restrictive antimicrobial formularies may inadvertently increase costs by promoting resistance.
Conclusions:
- Effective resistance control strategies must consider the unique role of genesis patients.
- A broad-spectrum antimicrobial formulary and real-time surveillance are crucial for timely and effective therapy.
- Addressing both patient and antibiotic factors is essential for combating antimicrobial resistance.